YHLO

All categories



Home

Technical Documents

GLINE-2019-nCoV Ag Speichel CGIA Arbeitsanleitung-Deutsch Ed

Category:

Time:

2021-05-21
UNION instrument operation SOP-A2

Category:

Time:

2020-01-02

GLINE-2019-nCoV Ag Speichel CGIA Arbeitsanleitung-Deutsch Ed

Category:

Time:

2021-05-21 10:28:05

UNION instrument operation SOP-A2

Category:

Time:

2020-01-02 14:22:50

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +